enkephalin, leucine has been researched along with Dystonia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamann, M; Kreil, A; Richter, A; Sander, SE | 1 |
| Alvarez-Fischer, D; Bandmann, O; Fritsch, B; Grundmann, M; Hartmann, A; Lu, L; Möller, JC; Oertel, WH; Samans, B; Schaefer, MK | 1 |
| Bantubungi, K; Blum, D; d'Alcantara, P; Galas, MC; Gall, D; Schiffmann, SN | 1 |
| Nobrega, JN; Parkes, JH; Raymond, R; Richter, A; Wong, P | 1 |
| Canevari, L; Heales, SJ; Jenner, P; Rose, S; Zeng, BY | 1 |
| Chesselet, MF; Clavel, N; Delfs, JM; Lorden, JF; Naudon, L | 1 |
| Brotchie, JM; Crossman, AR; Henry, B; Hille, CJ | 1 |
1 review(s) available for enkephalin, leucine and Dystonia
| Article | Year |
|---|---|
Opioid peptide precursor expression in animal models of dystonia secondary to dopamine-replacement therapy in Parkinson's disease.
Topics: Animals; Disease Models, Animal; Dopamine; Dystonia; Enkephalins; Parkinson Disease, Secondary; Protein Precursors | 1998 |
6 other study(ies) available for enkephalin, leucine and Dystonia
| Article | Year |
|---|---|
Changes in dynorphin immunoreactivity but unaltered density of enkephalin immunoreactive neurons in basal ganglia nuclei of genetically dystonic hamsters.
Topics: Animals; Animals, Genetically Modified; Basal Ganglia; Cricetinae; Disease Models, Animal; Dynorphins; Dystonia; Enkephalins; Female; Interneurons; Male; Mesocricetus; Neurons | 2011 |
Prolonged generalized dystonia after chronic cerebellar application of kainic acid.
Topics: Animals; Brain; Cerebellum; Disease Models, Animal; Dystonia; Enkephalins; HSP72 Heat-Shock Proteins; Kainic Acid; Neurons; Protein Precursors; Proto-Oncogene Proteins c-fos; Rats | 2012 |
The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity.
Topics: Adenosine; Animals; Behavior, Animal; Binding, Competitive; Body Weight; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Dystonia; Enkephalins; Hindlimb; Huntington Disease; In Vitro Techniques; Male; Mitochondria; Motor Activity; Neuroprotective Agents; Neurotoxins; Nitro Compounds; Propionates; Purinergic P1 Receptor Agonists; Rats; Rats, Inbred Lew; Reproducibility of Results; RNA, Messenger; Succinate Dehydrogenase; Synaptic Transmission; Treatment Outcome | 2002 |
Altered expression of preproenkephalin and prodynorphin mRNA in a genetic model of paroxysmal dystonia.
Topics: Analysis of Variance; Animals; Basal Ganglia; Brain; Chorea; Cricetinae; Disease Models, Animal; Dystonia; Enkephalins; Gene Expression Regulation; In Situ Hybridization; Mutation; Protein Precursors; Reference Values; RNA, Messenger; Tissue Distribution | 2004 |
Alterations in expression of dopamine receptors and neuropeptides in the striatum of GTP cyclohydrolase-deficient mice.
Topics: Animals; Autoradiography; Brain; Disease Models, Animal; Dystonia; Enkephalins; GTP Cyclohydrolase; In Situ Hybridization; Mice; Neuropeptides; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Presynaptic Terminals; Protein Precursors; Receptors, Dopamine; RNA, Messenger; Tachykinins; Tyrosine 3-Monooxygenase | 2004 |
Differential expression of glutamate decarboxylase messenger RNA in cerebellar Purkinje cells and deep cerebellar nuclei of the genetically dystonic rat.
Topics: Animals; Basal Ganglia; Cerebellar Nuclei; Dystonia; Enkephalins; Globus Pallidus; Glutamate Decarboxylase; In Situ Hybridization; Molecular Weight; Neostriatum; Purkinje Cells; Rats; Rats, Inbred Strains; RNA, Messenger | 1998 |